Risk Disclosure and the Recruitment of Oocyte Donors: Are Advertisers Telling the Full Story?

Lutjen P. Trounson A. Findlay J. Wood C. Renou P. , “The Establishment and Maintenance of Pregnancy Using In Vitro Fertilization and Embryo Donation in a Patient with Primary Ovarian Failure,” Nature 307, no. 5947 (1984): 174–175.

Centers for Disease Control (CDC) and U.S. Department of Health and Human Services, “2010 Assisted Reproductive Technology,” National Summary Report (2012): 1–75.

Bercovici M. , “Biotechnology Beyond the Embryo: Science, Ethics, and Responsible Regulation of Egg Donation to Protect Women's Rights,” Women's Rights Law Reporter 29, no. 4 (2008): 193–227;.

Durrell J. , “Women's Eggs: Exceptional Endings,” Hastings Women's Law Journal 22, no. 1 (2011): 187–245;.

Sauer M. V. Kavic S. M. , “Oocyte and Embryo Donation 2006: Reviewing Two Decades of Innovation and Controversy,” Reproductive Biomedicine Online 12, no. 2 (2006): 153–164.

Institute of Medicine and National Research Council of the National Academies, “Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research,” Workshop Report (2007);.

Bodri D. , “Complications Related to Ovarian Stimulation and Oocyte Retrieval in 4052 Oocyte Donor Cycles,” Reproductive Biomedicine Online 17, no. 2 (2008): 237–243;.

American Society for Reproductive Medicine (ASRM), “Repetitive Oocyte Donation,” Fertility and Sterility 90, Supp. 3 (2008): S194–S195;.

Jayaprakasan K. Herbert M. Moody E. Stewart J. A. Murdoch A. P. , “Estimating the Risks of Ovarian Hyperstimulation Syndrome (OHSS): Implications for Egg Donation for Research,” Human Fertility 10, no. 3 (2007): 183–187;.

Althuis M. D. Moghissi K. S. Westhoff C. Scoccia B. Lamb E. J. Lubin J. H. Brinton L. A. , “Uterine Cancer after Use of Clomiphene Citrate to Induce Ovulation,” American Journal of Epidemiology 161, no. 7 (2005): 607–615;.

Schneider J. , “Fatal Colon Cancer in a Young Egg Donor: A Physician Mother's Call for Follow-up and Research on the Long-Term Risks of Ovarian Stimulation,” Fertility and Sterility 90, no. 5 (2008): 2016e1–2016e5;.

Skillern A. A. Cedars M. I. Huddleston H. G. , “Ooctye Donors' Comprehension as Assessed by the EDICT (Egg Donor Informed Consent Tool),” Fertility and Sterility 101, no. 1 (2014): 248–51;.

Stewart L. M. Holman C. D. Hart R. Bulsara M. K. Preen D. B. Finn J. C. , “In Vitro Fertilization and Breast Cancer: Is There Cause for Concern?” Fertility and Sterility 98, no. 2 (2012): 334–340.

See Schneider , supra note 4;.

Ahuja K. K. Simons E. G. , “Cancer of the Colon in an Egg Donor: Policy Repercussions for Donor Recruitment,” Human Reproduction 13, no. 1 (1998): 227–231;.

Belkin L. , “An Egg Donor Responds,” New York Times, available at <http://parenting.blogs.nytimes.com/2011/07/22/an-egg-donor-responds/?_r=0>(last visted April 8, 2014).

See Institute of Medicine and National Research Council of the National Academies, supra note 4;.

Althuis , supra note 4;.

Bodri , supra note 4;.

ASRM, supra note 4;.

Jayaprakasan , supra note 4;.

Schneider , supra note 4.

Almeling R. , “Gender and the Value of Bodily Goods: Commodification in Egg and Sperm Donation,” Law and Contemporary Problems 72, no. 37 (2009): 37–58;.

Rao R. , “Coercion, Commercialization, and Commodification: The Ethics of Compensation for Egg Donors in Stem Cell Research,” Berkeley Technology Law Journal 21, no. 3 (2006): 1055–1066;.

Sauer Kavic , supra note 3;.

Steinbock B. , “Payment for Egg Donation and Surrogacy,” Mount Sinai Journal of Medicine 71, no. 4 (2004): 255–265.

Holland S. , “Contested Commodities at Both Ends of Life: Buying and Selling Gametes, Embryos and Body Tissues,” Kennedy Institute of Ethics Journal 11, no. 3 (2001): 263–284, at 274.

See Rao , supra note 7, at 1058.

Cohen M. A. Lindheim S. R. Sauer M. V. , “Donor Age Is Paramount to Success in Oocyte Donation,” Human Reproduction 14, no. 11 (1999): 2755–2758;.

see Steinbock , supra note 7.

See Steinbock , supra note 7, at 262.

Id.

Kenney N. J. McGowan M. L. , “Looking Back: Egg Donors' Retrospective Evaluations of Their Motivations, Expectations, and Experiences during Their First Donation Cycle,” Fertility and Sterility 93, no. 2 (2010): 455–466.

Id.

See Skillern Cedars Huddleston , supra note 4.

Id.;.

Daar J. F. , “Regulating the Fiction of Informed Consent in ART Medicine,” American Journal of Bioethics 1, no. 4 (2001): 19–20.

See Skillern Cedars Huddleston , supra note 4;.

see Daar , supra note 16;.

Belkin , supra note 5;.

Cahn N. Collins J. , “Fully Informed Consent for Prospective Egg Donors,” Virtual Mentor 16, no. 1 (2014): 49–56.

See Daar , supra note 16.

Lerner S. , “The Price of Eggs: Undercover in the Infertility Industry,” Ms. Magazine, March 1996.

Id.

American Society for Reproductive Medicine (ASRM), “Financial Compensation of Oocyte Donors,” Fertility and Sterility 88, no 2. (2007): 305–309, at 308.

See Cahn Collins , supra note 17;.

The Egg Donor Center, “Egg Donor Process,” available at <http://www.theeggdonor.com/egg_donor_process.html>; and <http://www.miami-ivf.com/index.php/en/services/becoming-an-egg-donor>(both last visited April 8, 2014).

Strong C. , “How Should IVF Programs Handle Initial Disclosure of Information to Prospective Ovum Donors?” American Journal of Bioethics 1, no. 4 (2001): 23–25.

Gurmankin A. , “Risk Information Provided to Prospective Oocyte Donors in a Preliminary Phone Call,” American Journal of Bioethics 1, no. 4 (2001): 3–13.

Cohen C. , “The Interests of Egg Donors: Who Is Deceiving Whom?” American Journal of Bioethics 1, no. 4 (2001): 20–21;.

Stock G. , “Eggs for Sale: How Much Is Too Much?” American Journal of Bioethics 1, no. 4 (2001): 26–27.

See Cohen , supra note 25;.

Gurmankin , supra note 24;.

Strong , supra note 23.

See Kenney McGowan , supra note 13.

Miller F. G. Shorr A. F. , “Advertising for Clinical Research,” IRB: Ethics and Human Research 21, no. 5 (1999): 1–4.

Id.

Klitzman R. Albala I. Siragusa J. Patel J. Appelbaum P. S. , “Disclosure of Information to Potential Subjects on Research Recruitment Web Sites,” IRB: Ethics and Human Research 30, no. 1 (2008): 15–20.

Id.

See ASRM, supra note 21, at 309.

Id.

Personal Communication from Sean Tipton to author (ADL) (January 10, 2014).

When collection of advertisements for this study was undertaken in November 2011 and when analysis of entities placing these advertisements was undertaken in 2012, ASRM made publicly available on its website a list of oocyte donor agencies that had registered with SART, signing an agreement to abide by ASRM guidelines. At the time of preparation of this article, ASRM no longer makes this list publicly available on its website. Our determination of the SART registration status of oocyte donor agencies that placed advertisements collected in November 2011 is based on the list that was publicly available on the ASRM website in June 2012.

Alberta H. B. Berry R. M. Levine A. D. , “Compliance with Donor Age Recommendations in Oocyte Donor Recruitment Advertisements in the USA,” Reproductive Biomedicine Online 26, no. 4 (2013): 400–405;.

Hawkins J. , “Financing Fertility,” Harvard Journal on Legislation 47, no. 1 (2010): 115–165;.

Keehn J. Holwell E. Abdul-Karim R. Chin L. J. Leu C. S. Sauer M. V. Klitzman R. , “Recruiting Egg Donors Online: An Analysis of In Vitro Fertilization Clinic and Agency Websites: Adherence to American Society for Reproductive Medicine Guidelines,” Fertility and Sterility 98, no. 4 (2012): 995–1000;.

Levine A. D. , “Self-Regulation, Compensation, and the Ethical Recruitment of Oocyte Donors,” Hastings Center Report 40, no. 2 (2010): 25–36;.

Luk J. Petrozza J. C. , “Evaluation of Compliance and Range of Fees Among American Society for Reproductive Medicine-Listed Egg Donor and Surrogacy Agencies,” Journal of Reproductive Medicine 53, no. 11 (2008): 847–852.

See Keehn , supra note 36;.

Carter J. R. Cezinski L. B. Karandikar-Chheda S. , “Comprehensive Review of Reproductive Egg Donation Web Sites,” Journal of Consumer Health on the Internet 16, no. 1 (2012): 53–65.

See Cahn Collins , supra note 17, at 49–50.

15 U.S.C. §§ 41–58 (2012).

21 CFR 1271 (2001).

SART, “National Summary,” available at <http://www.sart.org/find_frm.html>(last visited April 8, 2014);.

Miller J. , Analysis of AB 1317 (2009) for Committee on Health,” California State Assembly, available at <http://totalcapitol.com/?bill_id=200920100AB1317>(last visited April 8, 2014).

See supra note 35.

The one advertisement that contained the word “risk” and was coded as non-compliant with the ASRM guidelines used the term in reference to the possibility that a donor who had received a tattoo or body piercing in the last twelve months might pass infectious disease on to the intended mother or future child.

We note that, by its terms, the California law would require these “persons” to provide the specific risk disclosure set forth in the California law if they post the advertisements in California. We did not separately analyze whether or not these “personal” advertisements were posted in California and, if so, whether they included the risk disclosure required by California law.

See ASRM, supra note 21.

See <http://www.asrm.org/uploadedFiles/ASRM_Content/News_and_Publications/Ethics_Committee_Reports_and_Statements/financial_incentives.pdf>for the guidelines on the compensation of oocyte donors and <http://www.asrm.org/EthicsReports/>for a list of all ethics guidelines (both last visited April 8, 2014).

Beeson D. , “Dangerous Harvest,” Council for Responsible Genetics, available at <http://www.councilforresponsiblegenetics.org/genewatch/GeneWatchPage.aspx?pageId=312>(last visited April 12, 2014);.

Block M. , “Assembly Member Block Sends Letter to California Attorney General Urging Egg Donor Label Law Investigation,” available at <http://sd39.senate.ca.gov/news/2010-08-23-assemblymember-block-sends-letter-california-attorney-general-urging-egg-donor-label>(last visited April 8, 2014);.

Vorzimer A. , “An Undercooked Egg: California's New Oocyte Donation Statute Falls Woefully Short,” The Spin Doctor, available at <http://www.eggdonor.com/blog/2009/10/28/an-undercooked-egg-cali-fornias-new-oocyte-donation-statute-falls-woefully-short/>(last visited April 8, 2014).

Alberta, Berry, and Levine, supra note 36;.

Keehn Holwell Abdul-Karim Chin Leu Sauer Klitzman , supra note 36;.

Luk Petrozza , supra note 36.